Literature DB >> 15647917

Giant cell tumors of the knee: subchondral bone integrity affects the outcome.

Tain-Hsiung Chen1, Yu-Ping Su, Wei-Ming Chen.   

Abstract

From January 1992 to July 2001, we treated 38 patients with giant cell tumour in the knee region. Seventeen tumours were located in the distal femur and 21 in the proximal tibia . Twenty patients were classified as Campanacci grade II, 15 as grade III, and three as grade I. Patients' mean age was 34.5 (19-65) years, and the mean follow-up was 52 (24-134) months. Operative procedures were chosen according to the extent of bone and soft-tissue involvement. In 28 patients, intralesional curettage and bone grafting was performed and in ten patients a wide resection. We defined subchondral bone of the knee to be affected when the distance to the tumour was less than 3 mm. We then measured the area of affected subchondral bone radiographically using plain radiographs, CT, and MRI. In patients initially treated with curettage and bone grafting, the mean area of initially affected subchondral bone was 18.6 (0-81)%. The mean Enneking functional score at follow-up was 88 (66.6-100). There was a linear trend showing that the larger the area of affected subchondral bone, the worse the functional score. Among patients initially treated with wide resection, the mean area of affected subchondral bone was 68.2 (41-100)%. There was, however, no significant association between affected subchondral bone area and functional score.

Entities:  

Mesh:

Year:  2005        PMID: 15647917      PMCID: PMC3456951          DOI: 10.1007/s00264-004-0613-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  18 in total

1.  Customized treatment algorithm for giant cell tumor of bone: report of a series.

Authors:  William G Ward; Galaxy Li
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

2.  Giant-cell tumors of bone: an analysis of 87 cases.

Authors:  Yu-Ping Su; Wei-Ming Chen; Tain-Hsiung Chen
Journal:  Int Orthop       Date:  2004-05-25       Impact factor: 3.075

3.  Curettage and acrylic cementation in surgery of giant cell tumors of bone.

Authors:  B M Persson; H W Wouters
Journal:  Clin Orthop Relat Res       Date:  1976-10       Impact factor: 4.176

4.  Giant-cell tumor of bone. An analysis of two hundred and eighteen cases.

Authors:  R R Goldenberg; C J Campbell; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1970-06       Impact factor: 5.284

5.  Giant-cell tumor of bone around the knee.

Authors:  Y C Fong; T H Chen; W M Chen; W H Lo
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1997-04

6.  Cyclin alterations in giant cell tumor of bone.

Authors:  Adel Kauzman; Shu Qiu Li; Grace Bradley; Robert S Bell; Jay S Wunder; Rita Kandel
Journal:  Mod Pathol       Date:  2003-03       Impact factor: 7.842

7.  Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients.

Authors:  H W Sung; D P Kuo; W P Shu; Y B Chai; C C Liu; S M Li
Journal:  J Bone Joint Surg Am       Date:  1982-06       Impact factor: 5.284

8.  Curettage of benign lesions of bone. Factors related to recurrence.

Authors:  A Kreicbergs; P A Lönnqvist; B Nilsson
Journal:  Int Orthop       Date:  1985       Impact factor: 3.075

9.  Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.

Authors:  S M Kumta; L Huang; Y Y Cheng; L T C Chow; K M Lee; M H Zheng
Journal:  Life Sci       Date:  2003-08-01       Impact factor: 5.037

10.  Malignancy, aggressiveness, and recurrence in giant cell tumor of bone.

Authors:  N G Sanerkin
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

View more
  18 in total

1.  Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results.

Authors:  K Szalay; I Antal; J Kiss; M Szendroi
Journal:  Int Orthop       Date:  2006-09-13       Impact factor: 3.075

Review 2.  Giant cell tumour of bone: a new evaluating system is necessary.

Authors:  Han Wang; Ningjun Wan; Yongcheng Hu
Journal:  Int Orthop       Date:  2012-10-05       Impact factor: 3.075

Review 3.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

Review 4.  Giant Cell Tumor of Bone - An Overview.

Authors:  Anshul Sobti; Pranshu Agrawal; Sanjay Agarwala; Manish Agarwal
Journal:  Arch Bone Jt Surg       Date:  2016-01

5.  Treatment of giant cell tumor of bone: Current concepts.

Authors:  Ajay Puri; Manish Agarwal
Journal:  Indian J Orthop       Date:  2007-04       Impact factor: 1.251

6.  Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.

Authors:  Joseph Benevenia; Steven M Rivero; Jeffrey Moore; Joseph A Ippolito; Daniel A Siegerman; Kathleen S Beebe; Francis R Patterson
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

7.  Development and proposal of a scoring system for giant cell tumour of the bone around the knee.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Xiong-Gang Yang; Zhen Wang; Xiu-Chun Yu; Su-Jia Wu; Zhao-Ming Ye; Han Wang
Journal:  Int Orthop       Date:  2017-10-07       Impact factor: 3.075

8.  Preoperative CT for prediction of local recurrence after curettage of giant cell tumor of bone.

Authors:  Lenian Zhou; Shanyi Lin; Hanqiang Jin; Zhaoyuan Zhang; Changqing Zhang; Ting Yuan
Journal:  J Bone Oncol       Date:  2021-05-11       Impact factor: 4.072

9.  Giant Cell Tumor of Bone in Skeletally Immature Patients - A Clinical Perspective.

Authors:  Vipin Sharma; Seema Sharma; Kewal A Mistry; Bhanu Awasthi; Lucky Verma; Uttam Singh
Journal:  J Orthop Case Rep       Date:  2015 Oct-Dec

10.  Gait Analysis in Patients with Wide Resection and Endoprosthesis Replacement Around the Knee.

Authors:  Vivek Ajit Singh; Chan Wei Heng; Nor Faissal Yasin
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.